malondialdehyde has been researched along with Cardiomyopathy, Hypertrophic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Banach, M; Frycz-Kurek, AM; Gąsior, M; Jóźwiak, JJ; Macioł-Skurk, K; Małyszek-Tumidajewicz, J; Osadnik, T; Romuk, E; Skrzypek, M; Szczurek-Wasilewicz, W; Szyguła-Jurkiewicz, B | 1 |
| Chen, SN; Lombardi, R; Marian, AJ; Senthil, V | 1 |
2 other study(ies) available for malondialdehyde and Cardiomyopathy, Hypertrophic
| Article | Year |
|---|---|
Oxidative Stress Markers in Hypertrophic Cardiomyopathy.
Topics: Antioxidants; Cardiomyopathy, Hypertrophic; Female; Humans; Malondialdehyde; Middle Aged; Oxidants; Oxidative Stress | 2021 |
Antifibrotic effects of antioxidant N-acetylcysteine in a mouse model of human hypertrophic cardiomyopathy mutation.
Topics: Acetylcysteine; Animals; Antioxidants; Cardiomyopathy, Hypertrophic; Collagen; DNA; DNA, Mitochondrial; Echocardiography; Fibrosis; Gene Expression; Heart; Lipid Peroxidation; Malondialdehyde; Matrix Metalloproteinase 1; Mice; Mice, Transgenic; Myocardium; Procollagen; Reverse Transcriptase Polymerase Chain Reaction | 2006 |